Decision restores certainty to out-of-court debt restructurings
In a surprising 2014 decision, the District Court for the Southern District of New York held that the Trust Indenture Act ...
This memorandum highlights some considerations for the preparation of your 2016 annual report on Form 20-F. As in previous years, we discuss both disclosure developments as well as contin...
Life sciences companies are frequent targets of securities litigation. Often, when a company discloses bad news about a developing device or drug, the company’s stock price drops and pl...
Last Wednesday, the SEC issued a proposal aimed at eliminating or updating duplicative, overlapping and obsolete disclosure requirements. The proposal is welcome, but largely technical in...
On June 16, the SEC proposed rules aimed at overhauling and modernizing disclosure requirements for companies with material mining operations (excluding oil and gas) as part of its ongoin...
This memorandum highlights some considerations for the preparation of your 2015 annual report on Form 20-F. As in previous years, we discuss both disclosure developments as well as contin...
In the ongoing challenge to the SEC’s conflict minerals rule, the D.C. Circuit Court of Appeals, in a 2-1 decision, issued an opinion on August 18 upholding its April 2014 finding that ...
Boston-based biotech Intarcia Therapeutics announced this week that it had secured $225 million in aprivate synthetic royalty financing. The financing is in the form of limited recourse n...
Proxy access is back in the news and back on the agenda for many U.S. public companies. Four years after the DC Circuit invalidated the SEC’s proxy-access rule, we are seeing company-by...
This memorandum highlights some considerations for the preparation of your 2014 annual report on Form 20-F. As in previous years, we discuss both disclosure developments as well as contin...
